Macrophages are essential inflammatory cells which regulate the features of immune reactions within tumors. Many studies have reported their regulatory roles in immunity through cytokines and cell signaling. However, relatively few studies have focused on their metabolic features and mechanisms. We aimed to determine the signaling pathway regulating cell metabolism and the mechanism related to the regulation of human tumor-associated macrophages (TAMs) in gastric cancer (GC).
| INTRODUC TI ON
Macrophages are white blood cells that engulf exogenous and autogenous antigens and present to T cells to activate the immune system. Macrophages are present in almost all organs, some of which are tissue-resident (eg, histiocytes, Kupffer cells, alveolar macrophages, and microglia) and some are transformed monocytes derived from peripheral blood. All these cells belong to the mononuclear phagocyte system. [1] [2] [3] Monocytes/macrophages can differentiate into M1 or M2 macrophages following different stimulations.
Tumor-associated macrophages (TAMs) are similar to M2-polarized macrophages which can be stimulated by Th2 cytokines (interleukin [IL]-4, IL-10, and IL-13). Moreover, M1 and M2 (TAMs) cells can transform each other with appropriate stimuli, including cytokines and metabolites. 2, 3 Macrophages are the best-characterized tumor-infiltrating immune cells, and it is not surprising that they play a prominent active role in processes ranging from early carcinogenesis to tumor progression, including metastasis. 2 Currently, the majority of evidence supports the tumor-promoting role of a specific subpopulation of macrophages. Furthermore, macrophages can constitute up to 50%
of the tumor mass, forming a major component of the immune cell infiltrate in the tumor microenvironment (TME). 1, 4, 5 The antitumor to protumor roles of infiltrating macrophages are hot topics in oncoimmunology. To date, the common view on the potential reasons related to the transformation of TAMs is mainly based on tumor-specific factors and their downstream signaling, such as cytokines and chemokines. The metabolism-related mechanism has rarely been addressed. 1 Mammalian target of rapamycin signaling is the central mediator in cell metabolism, growth, proliferation, and survival. The activation of mTOR signaling is related to many cellular processes, such as insulin resistance, tumor development, and immune cell activation. 6 Thus, the extracellular regulation of mTOR activity is one of the connections linking TME and intratumor immune cells. Hypoxia is an essential feature in the neoplastic microenvironment.
The fast growth of tumors can cause widespread low oxygenation, thus inducing increased invasion and resistance to chemotherapy.
Genes (including noncoding RNAs) and signaling pathways related to the hypoxic microenvironment were extensively studied during the last decade. 9,10 Bandara et al 11 reported that in breast cancer lines, significant reductions in Dicer mRNA and protein levels were observed in cells exposed to hypoxia, which was partly mediated by feedback effects through microRNAs. Another study obtained similar results to ours, which showed that microRNA (miR)-30c was significantly downregulated in human renal cell carcinoma tissues and cell lines.
Mathew et al 12 found that miR-30c downregulation could be induced by hypoxia in renal cell carcinoma cells in a hypoxia-inducible factor (HIF)-dependent manner. There were studies concerning the roles of miR-30c in human gastric cancer (GC), regarding miR-30c as a potential biomarker for human GC diagnosis. However, very few studies have been reported concerning its role in GC TAMs.
Our preliminary data also indicated that the expression of miR-30c
was related to hypoxia in human GC, and it was a potential regulator of REDD1. Moreover, we found that REDD1, an mTOR negative regulator, was significantly decreased in GC-infiltrated macrophages, and its expression was associated with a decreased percentage of M1 macrophages in human GC. Therefore, to determine the reason for decreased miR-30c, mTOR activity, as well as the percentage of M1 in GC infiltrated macrophages, we undertook the studies outlined below. 
| MATERIAL S AND ME THODS

| Patients
| Cell lines and reagents
Human monocyte cell lines including THP-1 were purchased from ATCC. All cells were cultured in DMEM purchased from Gibco supplemented with 10% FBS (Invitrogen) and maintained in a humidified atmosphere containing 5% CO 2 at 37°C. For macrophage stimulation, THP-1 cells were treated with 100 ng/mL PMA (Sigma-Aldrich) for 2 days. The mTOR activator (MHY1485) was purchased from Millipore (500554). The HIF-1α inhibitor (cryptotanshinone, CPT) was purchased from Sigma-Aldrich (79852).
| Real-time PCR
Total RNA in GC-infiltrated macrophages was isolated using TRIzol reagent. The expression of miR-30C was detected using the TaqMan Advanced miRNA assay (A25576). The primers for genes used in the study were as follows: forward primer, TGAGGATGAACACTTGTGTGC; reverse primer, CCAACTGGCTAGGCATCAGC; amplicon size 110 bp for REDD1, and forward primer, TGTGGGCATCAATGGATTTGG; reverse primer, ACACCATGTATTCCGGGTCAAT, amplicon size 110 bp for GAPDH.
| Isolation of human GC-infiltrated macrophages and polarization stimulation
Fresh tissue-infiltrating macrophages were obtained according to the following procedure. 13 Briefly, cancer and peritumor tissues were cut into small pieces and digested in 100 U/mL collagenase type IV and 100 μg/mL DNase in RPMI + 10% FBS in RPMI-1640 
| Flow cytometry detection
| Western blot analysis
For western blotting, proteins were extracted from cultured cells using RIPA buffer containing PMSF (Beyotime). Equal amounts of protein (100 μg) were separated by 7.5%/12.5% SDS-PAGE and transferred to a PVDF membrane. Primary polyclonal Abs targeting HIF1a (ab92498), REDD1 (ab63059), mTOR Ser2481
(ab137133), mTOR Ser2448 (ab2486), mTOR (ab142349), and GLUT1 (ab652) were purchased from Abcam. The secondary Abs used were anti-rabbit HRP-linked (Abcam). The blots were developed using ECL reagent (Millipore). An equal amount of protein loading in each lane was confirmed using the β-actin Ab. ImageJ software (National Health Institute US) was used to quantify the integrated density of the band.
| Luciferase reporter assay and transfection of miR-30c
The 3′UTR region of REDD1 containing the WT or mutant potential target site for miR-30c was synthesized by Genescript and inserted into the pGL4.10[luc2] vector (Promega). For the luciferase assay, stimulated THP-1 cells were cotransfected with pGL4-REDD1-WT 3′UTR or pGL4-REDD1-MU 3′UTR, and miR-30c mimics or control (GenePharma) using Lipofectamine 2000 (Thermo Fisher Scientific).
Cells were harvested 48 hours after transfection and analyzed using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's protocol.
| Sample preparation and metabolomics determination
Ice-cold 50% methanol (5 mL) and 1 mL acetonitrile/methanol/ water (4:4:2, V/V) were added to resuspend and extract the macrophages, respectively. The cells were then broken by ultrasonication for 10 minutes (300 W). The supernatant was obtained by centrifugation at 680 g for 15 minutes. Metabolite extraction was subsequently carried out to isolate metabolites from the freezedried supernatant. Methanol (100 μL) was added to redissolve the samples, which were vortexed for 30 seconds, followed by centrifugation (6118 g, 15 minutes) at 4°C; the supernatant was used for metabolomics determination. Metabolic profiling was carried out on a UPLC Ultimate 3000 system (Dionex), coupled to an Orbitrap mass spectrometer (Thermo Fisher Scientific) in both positive and negative mode simultaneously. The chromatographic separation was undertaken on a 1.9 μm Hypersil Gold C 18 column (100 × 2.1 mm) (Thermo Fisher Scientific), and the column was 
| Statistical analysis
Data are presented as mean ± SD. The χ 2 test and Student's t test ANOVA were used to evaluate statistical differences in demographic and clinical characteristics. All expression experiments carried out in vitro were repeated at least 3 times with triplicate samples.
Pearson's correlation analysis was used to analyze the relationship between associated factors. Statistical analysis was undertaken using Stata 9.2 (StataCorp) and presented with GraphPad Prism software (GraphPad). In all cases, P < .05 was considered significant.
| RE SULTS
| Hypoxia-regulated miR-30c expression was associated with REDD1/mTOR signaling in tumorinfiltrating macrophages in human GC
To investigate the potential effects of miR-30c on REDD1 expression within TAMs, gene transcription was assessed. Both miR-30c
and REDD1 were significantly different between GC TAMs and normal control monocytes. Downregulated miR-30c and increased REDD1 were detected in GC TAMs ( Figure 1A,B) . Interestingly, we also found that the expression of miR-30c was negatively correlated with the expression of REDD1 in GC TAMs ( Figure 1C ), which might indicate that miR-30c can downregulate REDD1 within GC TAMs.
F I G U R E 1 Hypoxia-regulated microRNA (miR)-31c expression was associated with regulated in development and DNA damage responses 1 (REDD1)/mTOR in tumor-infiltrating macrophages in human gastric cancer (GC). A,B, The transcription of miR-30c (A) and REDD1 (B) was determined by using real-time PCR within macrophages extracted from GC (GC-M), paired adjacent tissues (Adjacent-M) (n = 68 for each group), and peripheral monocytes of healthy controls. C, Linear correlation between the expression of miR-30c and REDD1 was analyzed. D, Protein was extracted from tumor-infiltrating macrophages from miR-30c Low and miR-30c High groups (n = 9, each group).
Expression of hypoxia-inducible factor (HIF)-1α, REDD1, p-mTOR (s2448), mTOR, glucose transporter 1 (GLUT1), and β-actin were detected by using western blot. Data are presented as mean ± SD. Student's t test
In addition, the protein and REDD1/mTOR-related signaling activation were investigated using western blotting. First, GC patients were divided into 2 groups: miR-30c High and miR-30c
Low according to the lower 95% confidence interval of miR-30c expression in normal controls ( Figure 1A) . The results were similar to the real-time PCR results in that the REDD1 protein in the miR-30c High group was lower than that in the miR-30c Low group.
Activation of mTOR, downstream of REDD1, was also analyzed using mTOR Ab at the phosphate residue (2448), and TAMs mTOR activity in the miR-30c High group was higher than that in the miR-30c Low group. As mTOR activity is related to glycolysis level in most cells, 14 one of the hallmark proteins, glucose transporter 1 (GLUT1), was investigated. 15 It was found that the miR-30c
High group had higher expression of GLUT1, which could indicate that the TAMs in the miR-30c High group had a stronger glycolysis level than those in the miR-30c Low group. We also investigated HIF-1α expression within TAMs and found that the miR-30c High group had lower expression of HIF-1α compared with the miR-30c High group, which might indicate that HIF-1α might suppress the transcription of miR-30c in TAMs.
| High expression of miR-30c is related to increased glycolysis in TAMs
As mTOR is an essential gene related to cell metabolism, cell lysis was utilized in the metabolomics analysis. Thirteen metabolites related to glycolysis in 10 samples each from the miR-30c High and Low groups were analyzed using HPLC. The results indicated that miR-30c
High macrophages showed significantly enhanced glycolysis compared with the miR-30c Low macrophages (Figure 2A ). These results could be due to increased activation of mTOR, based on the previous results. We then confirmed that 3 metabolites (fructose 6 phosphate, pyruvate, 
| High expression of miR-30c is related to an increased percentage of M1 cells within TAMs
In addition to determining the metabolism of TAMs, we also detected the percentage of M1 cells in tumor-infiltrated macrophages. We used CD68 and inducible nitric oxide synthase (iNOS) double-positive cells to define M1 cells and found that the miR-30c High group had more M1 cells than the miR-30c Low group (P = .0001) ( Figure 3A) .
Similar results were also obtained using immunofluorescence staining, which showed that the percentage of iNOS in CD68 double-positive cells was significantly higher in the miR-30c High group compared with the miR-30c Low group ( Figure 3B ). These results could indicate that miR-30c is associated with the differentiation of M1 cells, and related to their metabolism.
| Hypoxia decreases transcription of miR-30c in macrophages due to HIF-1α activation
As miR-30 High macrophages showed low expression of HIF-1α, and previous publications have indicated that hypoxia can downregulate miR-30c expression through HIF-1α activation, [16] [17] [18] we postulated that HIF-1α could downregulate miR-30c expression in a hypoxic environment. We first compared the expression of miR-30c during hypoxia (1%) and normal O 2 concentration (21%), and the results indicated that miR-30c transcription was significantly decreased by hypoxia in THP-1 cells. However, we found that miR-30c could be restored by CPT which is a HIF-1α inhibitor ( Figure 4A ). We used western blotting to confirm the activation of HIF-1α both in hypoxia and hypoxia plus CPT treatment ( Figure 4B ). The results indicated that miR-30c was downregulated due to HIF-1α activation in macrophages.
| MicroRNA-30c promotes M1 differentiation and function by targeting REDD1
Based on the above investigation, we proposed that miR-30c can promote M1 cell differentiation and function through downregulation of REDD1. We first evaluated the possible binding of miR-30c to ) with gastric cancer (GC) TAMs were determined by using flow cytometry. The comparison was undertaken between miR-30c
Low and miR-30c High GC TAMs. B,
Percentage of M1 cells with GC TAMs was determined by using immunofluorescence staining (×100), the integrated optical density value of each figure was obtained by using Image J analyzing 5 random visions. All experiments were undertaken in triplicate. Data are presented as mean ± SD. Student's t test. MFI, mean fluorescence intensity the 3′UTR region of REDD1 using TargetScan (http://www.targetscan.org/vert_71/), and the results indicated that miR-30c had a potentially complementary 8 mer to the 3′UTR of REDD1 ( Figure 4C ).
We mutated the binding site in the 3′UTR of REDD1 and the promoter activity of REDD1 significantly decreased with the transfection of miR-30c, but was restored by the binding site mutation ( Figure 4C ). These results confirmed our hypothesis that REDD-1 was one of the potential targets of miR-30c.
We then overexpressed miR-30c in THP-1 cells, and M1 cell Figure 5C ). However, there was no apparent influence on the activity of mTORC2 (Ser2481) by the miR-30c/ REDD1 axis ( Figure 5C ).
| MicroRNA-30c can modify macrophage metabolism through mTOR activation
We also investigated cell glycolysis and found that glycolysis-related metabolites increased in response to the overexpression of miR-30c in THP-1-derived macrophages, these metabolites decreased due to overexpression of REDD1 and the inhibitor of miR-30c, and were boosted by the mTOR activator, MHY1485
( Figure 5D -F).
| D ISCUSS I ON
Tumor hypoxia is defined as relative oxygen deprivation due to fast tumor growth overloading blood supply, and the oxygen concentration is significantly lower than that in healthy tissues. To maintain continuous tumor growth during hypoxia, cancer cells have been found to alter their metabolism. Furthermore, hypoxia is known to change cell behavior and is associated with ECM remodeling and increased migratory and metastatic behavior. 19, 20 Hypoxia is reported to alter many cellular characteristics, including the transcriptome, proteomics, metabolomics, DNA repair, and apoptosis. MicroRNAs are regulated by hypoxia in many tissues. [21] [22] [23] [24] In the present study, our results indicated that miR-30c was also regulated by hypoxia-related HIF-1α activation.
MicroRNA-30c is a well-studied miRNA, and it is relevant in the tumorigenesis and development of many cancers, such as breast cancer, ovarian cancer, lung cancer, clear cell renal cell carcinoma, and gastric cancer. It also has potential diagnostic and prognostic implications, and represents a potential therapeutic target in cancers. 25, 26 However, some studies have found that miR-30c is not related to the prognosis of GC patients. 27 Other studies have reported similar results to those in our study, where pre-miR-30c transfection suppressed REDD1 expression in human osteoblast hFOB cells and resulted in cell death. Our data suggested that miR-30c can respond to hypoxia and results in increased REDD1 expression. We also confirmed that miR-30c could regulate REDD1 expression by targeting its 3′UTR.
28
Regulated in development and DNA damage responses 1 is a sensor protein in the stress response. It was first identified as a gene induced by hypoxia and DNA damage. 29, 30 It was also reported to respond to other environmental stresses, such as energy stress, glucocorticoid treatment, and reactive oxygen. 31, 32 Many studies have also indicated that REDD1 is involved in the regulation of mTORC1 signaling and is regarded as a crucial target of the ubiquitin-proteasome system. 33, 34 We found that REDD1 was increased in human GC-infiltrated macrophages, which induced a decrease in mTOR activity and a related decrease in the percent- In this study, we identified a novel metabolism-related signaling pathway, HIF-1α-miR-30c-REDD1/mTOR, in human GC TAMs. This signaling was associated with a decreased percentage of M1 cells and potentially induced an immune-suppressive TME ( Figure 6 ). Cellspecific therapy could be effective in the turn-over of the TME from the cell signaling-metabolism perspective.
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